The BLG & BRN reference didnt age well. it shows what the...

First 69 Last

Share
Profile

Follow
AM27

361 Posts.

31

22/02/19

18:48

Post #: 37536788
Share

Originally posted by mcm1636: ↑

Worth re-reading what TMT Analytics had to say in Nov last year and why they had a price target of 11 cents. 4DS has come far since then.

Buy rating reiterated
We believe 4DS’ technology transfer process has not been well-understood by the market, judging by the share price response to the 20 September announcement. In our view, the company is on track to deliver megabit memory vehicle results and a licensable14DS Memory Limitedproduction-compatible process flow to the semiconductor industry within the next 12 to 18 months. Alternatively, a trade sale should be possible as well. As such, we believe the company’s current valuation doesn’t do justice to the prospect of 4DS licensing or selling the technology within the next 12 to 18 months. Furthermore, as illustrated in Figure 1, peers such as BluGlass (ASX:BLG) and BrainChip (ASX:BRN), which are at a similar stage of development (BLG) or slightly ahead (BRN), are valued at more thantwice 4DS’ current valuation. For these reasons we reiterate our Buy recommendation for 4DS as well as our price target of A$ 0.11 per share.

Expand

The BLG & BRN reference didnt age well. it shows what the Australian sentiment to spec tech stocks is at the moment. probably the main reason 4DS hasnt returned to the 13c range.

4DS Price at posting: 7.2¢ Sentiment: Hold Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

SHN

Chimeric clocks $4.17M R&D tax rebate from Canberra

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Chaos reigns markets – so let's take stock of where we're at ahead of December

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MTM

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

OCN

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

There are more pages in this discussion • 68 more messages in this thread...

First 69 Last

Add 4DS (ASX) to my watchlist

(20min delay)
Last 8.4¢		Change 0.003(3.70%)		Mkt cap ! $123.4M

Open	High	Low	Value	Volume
8.2¢	8.4¢	8.1¢	$47.07K	570.6K

Buyers (Bids)

No.	Vol.	Price($)
2	490346	8.1¢

Sellers (Offers)

Price($)	Vol.	No.
8.4¢	181523	4

View Market Depth

No.	Vol.	Price($)
2	13000	0.071
1	10000	0.070
1	14463	0.069
7	444250	0.068
6	124792	0.067

Price($)	Vol.	No.
0.074	297895	4
0.075	95617	2
0.076	56520	2
0.077	80000	1
0.078	22000	2

Last trade - 16.10pm 29/11/2024 (20 minute delay)

4DS (ASX) Chart

The BLG & BRN reference didnt age well. it shows what the...

Top Stories

Chimeric clocks $4.17M R&D tax rebate from Canberra

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Chaos reigns markets – so let's take stock of where we're at ahead of December

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

Buyers (Bids)

Sellers (Offers)